LOS ANGELES (Legal Newsline) – A virtual pet game service is facing a lawsuit over allegations it violated California business codes.
John Doe, on behalf of himself and those similarly situated, filed a class-action lawsuit on Oct. 27 in the California Central District Court against Neopets, Inc. for allegedly violating California’s Automatic Renewal Law and California’s Unfair Competition Law, as well as for failure to obtain consumers’ consent and provide acknowledgement of automatic renewal.
The plaintiff alleges that Neopets, which provides a subscription for its virtual pet and games products/services, made automatic renewal or continuous service offers to consumers throughout California, but failed to present the terms in a clear and conspicuous manner and in visual proximity to the request for consent to the offer before the subscription or purchasing agreement was fulfilled. The plaintiff also alleges that the defendants charged the plaintiff’s credit or debit card, or third-party account without first obtaining the plaintiff’s consent. The plaintiff argues that the defendant failed to provide an acknowledgment that includes the automatic renewal or continuous service offer terms, cancellation policy, and information regarding how to cancel.
The plaintiff is suing for damages and full restitution in the amount of the subscription payments already made. He also wants injunctive relief, attorney costs and any other rewards deemed just by the court. The plaintiff is represented by Scott J. Ferrell, Richard H. Hikida, David W. Reid and Victoria C. Knowles of the office of Newport Trial Group in Newport Beach, California.
U.S. District Court, California Central District Court Case number 2:15-cv-08395-DMG-PLA
Full Article – http://legalnewsline.com/stories/510646459-neopets-accused-for-violating-california-business-law
The settlement is subject to review by the US Federal Trade Commission and the US department of justice, Sun Pharma said. Photo: Bloomberg
Mumbai: Ranbaxy Pharmaceuticals Inc., a unit of Sun Pharmaceutical Industries Ltd, has settled a patent litigation with Actavis over the generic version of Absorica, a drug used to treat acne.
Ranbaxy, along with its partners, Cipher Pharmaceuticals Inc. and Galephar Pharmaceutical Research, Inc. have entered into a settlement with Actavis that dismisses the lawsuit relating to Actavis’s abbreviated new drug application (ANDA) for a generic version of Absorica (isotretinoin capsules), Sun Pharma said.
Absorica is used to treat severe recalcitrant nodular acne, a skin disease, in patients 12 years of age and older.
As part of the agreement, Ranbaxy, Cipher and Galephar have entered into a non-exclusive license agreement with Actavis under which Actavis may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or earlier under certain circumstances, it said.
In 2014, Ranbaxy had introduced Absorica 25 mg and 35 mg capsules in the US after the product was licensed from Cipher Pharmaceuticals, Inc.
The settlement is subject to review by the US Federal Trade Commission and the US department of justice, Sun Pharma said.
Translation: No, you won’t be seeing the film anytime soon.
Production company Emmett/Furla Oasis has filed a $10 million lawsuit against Morgan Creek Productions. Both companies are producing the anticipated Tupac biopic; however, Emmett/Furla claims that Morgan Creek cast its Tupac Shakur without their permission—a breach of their contract. According toThe Hollywood Reporter, Morgan Creek agreed to let Emmett/Furla have sole approval of the film’s director and the lead actor.
This latest development (if you can call it that) has hardly been the film’s only setback. John Singleton, who worked with the rapper and Janet Jackson in 1993’s Poetic Justice, was set to direct the biopic but then exited production in April. He now wants to direct a Tupac film of his own. “The people involved [in the biopic] aren’t really respectful of the legacy of Tupac,” John said at the time on Instagram. Carl Franklin is now set to direct.
Tupac is more than deserving of a film about his life. Among other life events, he started rapping while enrolled in a performing arts school, only for his mother Afeni to miss the early years of his music career because she got addicted to crack cocaine. Politicians feared him as he faced death threats. He survived several shootings as he rapped about how he was going to die at a young age, all before he was fatally shot at 25.
The National Federation of Independent Business (NFIB) Small Business Legal Center is urging the Supreme Court to take a case out of California that questions whether a city can constitutionally force developers to sell certain housing units below market rates.
The case, California Building Industry Association v. City of San Jose, Calif., centers on a city rule that requires developers to set aside 15 percent of all newly constructed residential units for the city to use as affordable housing stock or opt out by paying a fee.
NFIB Small Business Legal Center is asking the Supreme Court to hear the case and reverse the California Supreme Court decision upholding the housing rule.
“Here we have the city of San Jose trying to use its power to bully landowners,” Karen Harned, the group’s executive director said in a news release. “Clearly, the constitution protects private property and the right of landowners to exercise their right to use and sell their property at market rate. The court should stop San Jose and other cities with similar schemes.”
The legal arm of the nation’s leading small-business association said the court should settle the lower court split and follow the legal precedence it set in Nollan v. California Coastal Commission. In that case, the court held that the government couldn’t require a landowner to dedicate property as a condition of a permit approval.